TP73
protein-codingtumor protein p73
Gene summary
This gene encodes a member of the p53 family of transcription factors involved in cellular responses to stress and development. It maps to a region on chromosome 1p36 that is frequently deleted in neuroblastoma and other tumors, and thought to contain multiple tumor suppressor genes. The demonstration that this gene is monoallelically expressed (likely from the maternal allele), supports the notion that it is a candidate gene for neuroblastoma. Many transcript variants resulting from alternative splicing and/or use of alternate promoters have been found for this gene, but the biological validity and the full-length nature of some variants have not been determined. [provided by RefSeq, Feb 2011]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~83.7 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0030346
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0030346
Submitter: ClinGen
The *TP73* gene encodes a transcription factor belonging to the p53 family and controls cell proliferation and cell death, as well as the architecture and homeostasis of various tissues (PMID: 34368167). *TP73* has been reported as an essential positive regulator of lung ciliated cell differentiation (PMID: 34077761) as well as an activator of FOXJ1 expression (PMID: 26988441). *TP73* was first reported as a candidate gene linked to primary ciliary dyskinesia 47 and lissencephaly in 2021 (Wallmeier et al., PMID: 34077761). The specific disease entity, primary ciliary dyskinesia 47 and lissencephaly (CILD47, MONDO:0030346, OMIM#: 619466), is part of a larger group of more than 40 forms of primary ciliary dyskinesia (PCD) with a monogenic etiology. Autosomal-recessive motile ciliopathy is triggered by loss-of-function variants in *TP73* leading to impaired differentiation of multiciliated cells (MCC). This defect is the underlying cause of a severe, chronic, and destructive pulmonary disease, as well as abnormalities in the development of the cerebral cortex. The 2021 study described seven patients from five non-related families with a history of consanguinity who experienced chronic respiratory conditions affecting both upper and lower airways, characterized by repeated infections, a productive cough, persistent rhinitis, and frequent otitis media (PMID: 34077761). Some patients exhibited these symptoms very early on, with onset in the neonatal period necessitating respiratory support. One patient required medical intervention at two months old due to respiratory failure complications. Chest radiographs indicated conditions such as atelectasis, mucus obstruction, and bronchiectasis. However, there was no occurrence of situs inversus among these individuals. Additionally, these patients had brain irregularities that closely resembled patterns of anterior focused lissencephaly, often accompanied by a thin, poorly developed, or completely absent corpus callosum. These neurological abnormalities were associated with a spectrum of intellectual disabilities, central hypotonia, and evidence of increased seizure susceptibility (PMID: 34077761). Respiratory epithelial cells from patient samples harboring TP73 variants were cultured under an air-liquid interface (ALI) and showed a reduced number of FOXJ1- and RFX2-positive multi-ciliated cells, a reduction in ciliary length, a severe defect in differentiation, and an inability to transport particles by ciliary beating *in vitro* (PMID 34077761). Five suspected disease-causing variants have been scored as part of this curation (one multi-exon deletion, one frameshift, two nonsense, and one canonical splice site disruption introducing a premature stop codon). These variants have been collectively reported in five probands in one publication, all of whom were homozygous for their respective variants (PMID: 34077761). The parents of these individuals were found to be heterozygous carriers of the respective variants. This gene-disease relationship is also supported by experimental evidence. *TP73* expression in humans is found in ciliated-related organ tissue such as the lung and testis (PMID: 24309898). A pooling-based genome-wide association study reported a link between p73 and chronic rhinosinusitis in a human population (PMID: 20211107). Animal models have shown that mice functionally deficient in p73 exhibited profound neurological defects, hydrocephalus, chronic infections, and inflammation. Histologically, the p73-/- mice developed severe rhinitis and purulent otitis media, and massive neutrophil infiltrates of these sites were evident at the earliest ages and persisted through adulthood when greater than 80% of p73-/- mice exhibited chronic, bilateral rhinitis, otitis, periorbital edema, and conjunctivitis (PMID:10716451). The same finding was replicated by Nemajerova et al., 2016 (PMID: 27257214) with similar upper and lower airway phenotypes. A separate mouse model was created, demonstrating that mice deficient in p73 display pronounced airway abnormalities including epithelial hyperplasia, loss of epithelial integrity, and the absence of multiciliated cells (MCC). Additionally, these mice showed clear signs of lung infection and inflammation, including the accumulation of debris, mucus, and inflammatory cells within the bronchioles, leading to crystalline pneumonia (PMID: 26947080). Isolated murine tracheal epithelial cells (MTECs) from these mice demonstrated a significant change in the cellular composition of epithelium from murine tracheas and bronchioles and reduced ciliated cells compared to the wild-type controls. p73 regulates Foxj1 as a transcriptional regulator in multi-ciliogenesis (PMID: 26947080). Finally, a mouse model has recapitulated the neurological feature of immature and aberrant multi-ciliated ependymal cells that persist in adulthood (PMID: 26482843). In summary, *TP73* is strongly associated with primary ciliary dyskinesia 47 and lissencephaly. This has been demonstrated in both clinical diagnostic and research settings without the emergence of contradictory evidence, leading to a strong classification. Replication over a longer period will be required to reach a more definitive gene-disease association. The ClinGen Motile Ciliopathy GCEP approved this classification on September 14, 2023 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0030346
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious; Neurologic; Pulmonary
Intervention: Allergy/Immunology/Infectious; Pulmonary
Rationale: Among other features, the condition can include susceptibilty to respiratory infections and difficulties with mucociliary clearance, and awareness may allow preventative measures and early and aggressive treatment of infections
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to TP73 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_005427.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 13 | 3 | 17 | ||
| missense | 93 | 6 | 1 | 100 | ||
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 1 | 1 | 1 | 3 | ||
| splice donor/acceptor (+/-2bp) | 1 | 1 | 2 | |||
| Total | 4 | 1 | 96 | 19 | 4 | 124 |
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_005418.1 | 13 | MANE Select | |
| Ensembl | ENSP00000367545.4 | 13 | MANE Select | |
| RefSeq | NP_001119712.1 | 12 | Standard | |
| RefSeq | NP_001119713.1 | 11 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| tp73 | Danio rerio | Structure: ceratobranchial cartilage Quality: decreased size abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Neurotrophin signaling pathway - Homo sapiens (human)
- p53 signaling pathway - Homo sapiens (human)
- Hippo signaling pathway - Homo sapiens (human)
- Measles - Homo sapiens (human)
- TP53 Network
Biological Process
- activation of MAPK activity
- kidney development
- mismatch repair
- cellular response to DNA damage stimulus
- cell cycle arrest
Molecular Function
- RNA polymerase II proximal promoter sequence-specific DNA binding
- DNA-binding transcription factor activity, RNA polymerase II-specific
- DNA-binding transcription activator activity, RNA polymerase II-specific
- p53 binding
- DNA-binding transcription factor activity
Cellular Component
- chromatin
- nucleus
- nucleoplasm
- mitochondrion
- Golgi apparatus
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000378295
- Coding exons
- 13
- Length
- 83682
- Individuals with no LoFs
- 125688
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 8
- Defined
- 125696
- p
- 0.0000318
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 1.85 | 322 | 430 | 0.749 | 0.0000280 | 4147 |
| Missense (PolyPhen) | 93 | 167.17 | 0.55633 | 1520 | ||
| Synonymous | -1.17 | 206 | 186 | 1.11 | 0.0000135 | 1246 |
| Loss of Function | 4.59 | 3 | 30.3 | 0.0991 | 0.00000156 | 313 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0 | 0.0 | absent |
| Latino/Admixed American | 0.000030 | 0.000029 | rare |
| Ashkenazi Jewish | 0.00010 | 0.000099 | rare |
| East Asian | 0 | 0.0 | absent |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.0000089 | 0.0000088 | rare |
| South Asian | 0.00013 | 0.00013 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Participates in the apoptotic response to DNA damage. Isoforms containing the transactivation domain are pro-apoptotic, isoforms lacking the domain are anti-apoptotic and block the function of p53 and transactivating p73 isoforms. May be a tumor suppressor protein. {ECO:0000269|PubMed:10203277, ECO:0000269|PubMed:11753569, ECO:0000269|PubMed:18174154}.;
Recessive Scores
- pRec
- 0.301
Intolerance Scores
- LoFtool
- 0.0179
- RVIS EVS
- -1.73
- RVIS percentile EVS
- 2.44
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.909
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |